The improvement of prognosis in gastric cancer patients with positive AdipoR1 expression might be affected by organ protective effects from insulin resistance and inflammatory states rather than as a result of a direct antiproliferative effect via globular adiponectin. The gene discussed is ADIPOR1; the disease is gastric cancer.